News stories about McKesson (NYSE:MCK) have been trending somewhat positive on Monday, according to Accern Sentiment Analysis. The research firm ranks the sentiment of news coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. McKesson earned a news sentiment score of 0.16 on Accern’s scale. Accern also assigned news articles about the company an impact score of 46.4930371831308 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near future.
Here are some of the news articles that may have impacted Accern Sentiment Analysis’s analysis:
- Future outlook of “EHR-EMR market” is expected to reach USD 120 billion in 2023 and CAGR will Grow at a 10.9% (medgadget.com)
- An Exclusive Interview With DeRay Mckesson’s Vest (theroot.com)
- Global Colposcopy Market Report (2018-2023) with Key Players DySIS, CooperSurgical, Atmos, Olympus, Karl Kaps, McKesson, Danaher, and Carl Zeiss – ResearchAndMarkets.com (markets.financialcontent.com)
- McKesson Co. (MCK) Receives Average Rating of “Hold” from Analysts (americanbankingnews.com)
- Bonafide Announces Improved Supply Chain Connectivity Based on McKesson Integration (money.ca)
Shares of McKesson (NYSE:MCK) traded up $2.01 during mid-day trading on Monday, reaching $157.80. 1,304,485 shares of the company’s stock traded hands, compared to its average volume of 1,790,000. The company has a quick ratio of 0.61, a current ratio of 1.07 and a debt-to-equity ratio of 0.63. McKesson has a 12-month low of $133.82 and a 12-month high of $178.86. The firm has a market cap of $32,560.00, a price-to-earnings ratio of 7.59, a P/E/G ratio of 1.48 and a beta of 1.29.
The company also recently disclosed a quarterly dividend, which will be paid on Monday, April 2nd. Stockholders of record on Thursday, March 1st will be paid a dividend of $0.34 per share. The ex-dividend date is Wednesday, February 28th. This represents a $1.36 annualized dividend and a dividend yield of 0.86%. McKesson’s dividend payout ratio is presently 6.54%.
Several equities research analysts recently commented on the stock. Robert W. Baird reaffirmed a “buy” rating and issued a $200.00 price objective on shares of McKesson in a research report on Wednesday, January 17th. Zacks Investment Research raised shares of McKesson from a “hold” rating to a “buy” rating and set a $164.00 price objective on the stock in a research report on Wednesday, February 14th. Evercore ISI assumed coverage on shares of McKesson in a research report on Thursday, January 4th. They issued an “outperform” rating and a $179.00 price objective on the stock. ValuEngine cut shares of McKesson from a “buy” rating to a “hold” rating in a research report on Sunday, December 31st. Finally, Barclays assumed coverage on shares of McKesson in a research report on Thursday. They issued an “equal weight” rating and a $165.00 price objective on the stock. Two investment analysts have rated the stock with a sell rating, eight have issued a hold rating and nine have assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus price target of $176.74.
In other news, SVP Erin M. Lampert sold 1,413 shares of the business’s stock in a transaction dated Thursday, March 1st. The shares were sold at an average price of $149.38, for a total transaction of $211,073.94. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Chairman John H. Hammergren sold 65,000 shares of the business’s stock in a transaction dated Thursday, December 14th. The stock was sold at an average price of $160.00, for a total transaction of $10,400,000.00. The disclosure for this sale can be found here. 1.20% of the stock is owned by insiders.
ILLEGAL ACTIVITY NOTICE: This report was originally posted by BBNS and is the sole property of of BBNS. If you are accessing this report on another domain, it was illegally copied and reposted in violation of US & international copyright & trademark law. The correct version of this report can be accessed at https://baseballnewssource.com/2018/03/12/mckesson-mck-getting-somewhat-positive-media-coverage-analysis-finds/2020033.html.
McKesson Corporation is a healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology company. The Company provides medicines, medical products and healthcare services by partnering with pharmaceutical manufacturers, providers, pharmacies, governments and other organizations in healthcare.
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.